News for Healthier Living

New Research Shows Blood Test May Offer Early Warning of Liver Cancer Recurrence After Liver Transplant

A personalized blood test known as a circulating tumor DNA (ctDNA) test--which detects tiny fragments of cancer DNA circulating in the bloodstream--may help identify liver cancer recurrence earlier in transplant recipients and reduce the need for invasive procedures, according to a new study from Houston Methodist.

January 20, 2026


January 20 2026

January 19 2026

January 18 2026

January 17 2026

January 16 2026

January 15 2026

January 14 2026

January 13 2026

January 12 2026

January 11 2026

January 10 2026

January 9 2026

January 8 2026

January 7 2026

January 6 2026